CClinicalTrials.gg
RecruitingNCT02279550Updated Mar 8, 2024

Institutional Registry of Hip Fracture in the Elderly

An observational study in Hip Fracture, sponsored by Hospital Italiano de Buenos Aires. Recruiting at 1 site in Argentina. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2024-03-08.

Sponsored by Hospital Italiano de Buenos Aires · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,000
Ages
65 Years and older
Sex
All
01

Study summary

The purpose of this study is to create an institutional and population-based registry of Hip fracture in the elderly with a prospective survey based on epidemiological data, risk factors, diagnosis, prognosis, treatment, monitoring and survival.

Read the detailed description

All patients over 65 years old who are admitted to the orthopedic and traumatology ward diagnosed with hip fracture will be assessed.

The generation of the list of potentially evaluable patients will be performed daily.

Once defined patient inclusion, an intern take oral informed consent and will proceed to complete the CRF.

Cohort will be followed at 3 months and a second follow-up at year.

Variables to be measured:

Patient Data Comorbidities Charlson score Scales functionality Factors prior to the fall Medications Trauma variables Complications Mortality

02

Conditions studied

  • Hip Fracture

Keywords

  • hip fracture, elderly
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 100 across 675 observational studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Hospital Italiano de Buenos Aires is the lead sponsor of 128 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

aged >65 hip fracture

Inclusion criteria

  1. Patients over 65 with hip fracture.
  2. Admission to HIBA
  3. Followed by any health care provider. -

Exclusion criteria

Exclusion Criteria:

1 Patient refuses to participate in the registration or informed consent process

-

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,000 participants (estimated)
Target follow-up
20 Years
Patient registry
Yes

Groups and cohorts

  • hip fracture

    aged \>65 with hip fracture

06

What researchers measure

Primary outcomes

  1. mortality

    Time frame: 1 year

Secondary outcomes

  1. frailty (measured by the Rockwood Scale)

    It will performed once included in the Register the Rockwood Scale of Frailty and year follow-up after.

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
  • Hospital Italiano de Buenos Aires
    Ciudad Autonoma de Buenos Aires, Buenos Aires 1199, Argentina
    Recruiting
08

References and documents

Publications

  • Wolinsky FD, Fitzgerald JF, Stump TE. The effect of hip fracture on mortality, hospitalization, and functional status: a prospective study. Am J Public Health. 1997 Mar;87(3):398-403. doi: 10.2105/ajph.87.3.398. PubMed 9096540 ↗
  • Hannan EL, Magaziner J, Wang JJ, Eastwood EA, Silberzweig SB, Gilbert M, Morrison RS, McLaughlin MA, Orosz GM, Siu AL. Mortality and locomotion 6 months after hospitalization for hip fracture: risk factors and risk-adjusted hospital outcomes. JAMA. 2001 Jun 6;285(21):2736-42. doi: 10.1001/jama.285.21.2736. PubMed 11386929 ↗
  • Alarcon Alarcon T, Gonzalez-Montalvo JI. [Osteoporotic hip fracture. Predictive factors of short-and long-term functional recovery]. An Med Interna. 2004 Feb;21(2):87-96. doi: 10.4321/s0212-71992004000200010. No abstract available. Spanish. PubMed 14974897 ↗
  • Robinson TN, Eiseman B, Wallace JI, Church SD, McFann KK, Pfister SM, Sharp TJ, Moss M. Redefining geriatric preoperative assessment using frailty, disability and co-morbidity. Ann Surg. 2009 Sep;250(3):449-55. doi: 10.1097/SLA.0b013e3181b45598. PubMed 19730176 ↗
  • Riera-Espinoza G. Epidemiology of osteoporosis in Latin America 2008. Salud Publica Mex. 2009;51 Suppl 1:S52-5. doi: 10.1590/s0036-36342009000700009. PubMed 19287895 ↗
  • Benchimol J, Fiorentini F, Elizondo CM, Boietti BR, Carabelli G, Barla J, Sancineto C, Waisman GD, Giunta DH. Institutional Registry of Elderly Patients With Hip Fracture in a Community-Based Tertiary Care Hospital in Argentina (RIAFC). Geriatr Orthop Surg Rehabil. 2016 Sep;7(3):121-5. doi: 10.1177/2151458516651309. Epub 2016 Jun 15. PubMed 27551569 ↗

Study documents

  • Study protocol · Mar 17, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02279550
Lead sponsor
Hospital Italiano de Buenos Aires
Responsible party
Javier Alberto Benchimol (MD, Hospital Italiano de Buenos Aires) — Principal investigator
First posted
Oct 31, 2014
Start date
Nov 2016
Primary completion
Dec 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Mar 8, 2024

Study contacts

Diego H Giunta, MD
Contact
diego.giunta@hospitalitaliano.org.ar
5411-9590200 ext. 4419
Javier A Benchimol, MD
Contact
javier.benchimol@hospitalitaliano.org.ar
Javier A Benchimol, MD
principal investigator · Hospital Italiano de Buenos Aires

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion